Skip to content
WeighLab
Menu
Ranked #129 · Grade C

Oak review

Publishes nine different "starting" prices and attaches a term to none of them — the two cheapest appear only beside a $200-off badge its own affiliate page defines as a three-month package, so this ranking files no figure for Oak at all.

Visit Oak Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning
Tirzepatide
$300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning
Coverage
45 states (list not published)
Brand-name
Compounded only

The Index scorecard

Oak scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency40/100
Nationwide Access80/100
Formulation Options84/100
Clinical Oversight84/100
Contract Flexibility82/100

Where the value is

  • A non-injectable route alongside the two weekly injections — sublingual drops or tablets targeting the GLP-1 pathway — which most programs at this end of the ranking do not offer at all
  • LegitScript-certified, provider-reviewed, no video call required, with free shipping and free health coaching included
  • Its own comparison tables do print undiscounted floors — $167/mo on the homepage, $190/mo on /weight-loss — so a reader who scrolls past the hero at least sees figures that are not a package discount in a monthly slot
  • Oak claims one price at every dosage and no subscription; if that holds, titrating from 0.25mg to 2.4mg costs nothing extra, which is where most flat-looking programs quietly get expensive

The tradeoffs

  • It publishes NINE different "starting" prices — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term, a plan length or a billing cadence to not one of them
  • The $119 and $185 in the homepage hero appear only beside a "$200 off — new patient offer", and Oak's own affiliate page defines that offer as "$50 off your first month, $200 off 3-months" — a three-month package discount presented as a monthly rate
  • The two floors it publishes with no discount attached, $167/mo in the homepage comparison table and $190/mo on /weight-loss, disagree with each other and neither says what term buys it
  • The real ladder sits behind a 29-question health intake, so no monthly figure can be filed for either molecule, no annual cost can be modeled, and no price at all is published for the oral/sublingual route
  • "All doses are the same price" is Oak's claim rather than a verified fact — a reading of its own checkout copy recorded each dose step costing roughly $50 to $75 more
  • 45 states per its own Terms of Use — not all 50 — and it never publishes which 45
  • The compounding pharmacies are never named, and the operating entity is given three ways on its own site (Leaf Longevity Holdings Corp. DBA Oak Longevity, Oak Longevity Holdings Corp., and Oaklovesyou LLC)
  • Once a provider has prescribed and the order reaches the pharmacy it is non-refundable, per its Terms
  • Compounded only — no FDA-approved Wegovy, Zepbound, Ozempic or Mounjaro route

The bottom line

Best for: Shoppers willing to complete a long health intake before they see a price, who want the non-injectable route on the same account as the two weekly injections and will confirm the number Oak quotes them rather than the one on its homepage. Publishes nine different "starting" prices and attaches a term to none of them — the two cheapest appear only beside a $200-off badge its own affiliate page defines as a three-month package, so this ranking files no figure for Oak at all.

Ranked #129 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Oak.

The 24 programs nearest this one

Pricing, states and verification reflect Oak's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Oak's site. Not medical advice; see our disclosure.

← Back to the value leaderboard